published meta-analysis   sensitivity analysis   studies

vaccines in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias intracranial hemorrhage detailed resultsLi J, 2022 1.03 [0.02; 52.46] 1.03[0.02; 52.46]Li J, 202210%299NAnot evaluable ischemic strokedetailed resultsLi J, 2022 1.03 [0.02; 52.46] 1.03[0.02; 52.46]Li J, 202210%299NAnot evaluable Myocardial infarction detailed resultsLi J, 2022 1.03 [0.02; 52.46] 1.03[0.02; 52.46]Li J, 202210%299NAnot evaluable pulmonary embolismdetailed resultsLi J, 2022 1.03 [0.02; 52.46] 1.03[0.02; 52.46]Li J, 202210%299NAnot evaluable venous thromboembolism detailed resultsLi J, 2022 1.03 [0.02; 52.46] 1.03[0.02; 52.46]Li J, 202210%299NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-10 17:50 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 551,834,763,922,935,620,1317,1265,824,766,857,1291,1088,1331,1330,1329,1344,1328,1327,979,822,762,805,950,757,761,806,758,826,755,821,1288,1287,1286,760,1284,802,765,1285,759,823,804,1264,764,858,835,1262,1290,1316,1341,1342,1343,825,803 - roots T: 290